Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.61 USD | +1.63% | +13.03% | -13.80% |
May. 14 | Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading | MT |
May. 14 | Pliant Therapeutics Reports Positive Topline Data in Idiopathic Pulmonary Fibrosis Trial | MT |
Financials (USD)
Sales 2024 * | 1.54M | Sales 2025 * | 6.3M | Capitalization | 942M |
---|---|---|---|---|---|
Net income 2024 * | -208M | Net income 2025 * | -245M | EV / Sales 2024 * | 363 x |
Net cash position 2024 * | 380M | Net cash position 2025 * | 393M | EV / Sales 2025 * | 87.2 x |
P/E ratio 2024 * |
-4.57
x | P/E ratio 2025 * |
-4.12
x | Employees | 158 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.59% |
Latest transcript on Pliant Therapeutics, Inc.
1 day | +1.63% | ||
1 week | +13.03% | ||
Current month | +32.06% | ||
1 month | +17.72% | ||
3 months | -6.19% | ||
6 months | +15.63% | ||
Current year | -13.80% |
Managers | Title | Age | Since |
---|---|---|---|
Bernard Coulie
CEO | Chief Executive Officer | 58 | 16-01-31 |
- | - | ||
Keith Cummings
DFI | Director of Finance/CFO | 47 | 18-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 21-01-11 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 16-06-30 |
Gayle Crowell
BRD | Director/Board Member | 73 | 20-01-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 2 M€ | -.--% | ||
0.08% | 0 M€ | 0.00% | - | |
0.07% | 234 M€ | +6.34% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 15.61 | +1.63% | 427,717 |
24-05-15 | 15.36 | +8.63% | 1,269,936 |
24-05-14 | 14.14 | +3.44% | 974,195 |
24-05-13 | 13.67 | -1.01% | 392,358 |
24-05-10 | 13.81 | 0.00% | 487,214 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.80% | 942M | |
+32.36% | 694B | |
+31.16% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.74% | 239B | |
+10.02% | 209B | |
-3.23% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- PLRX Stock